Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C

The antibody response to the SARS-CoV-2 Omicron variant is not well studied in children. Here, the authors provide an age-stratified analysis of SARS-CoV-2 neutralizing capacity of sera from children with acute or convalescent COVID-19 as well as children with multisystem inflammatory syndrome.

Bibliographic Details
Main Authors: Juanjie Tang, Tanya Novak, Julian Hecker, Gabrielle Grubbs, Fatema Tuz Zahra, Lorenza Bellusci, Sara Pourhashemi, Janet Chou, Kristin Moffitt, Natasha B. Halasa, Stephanie P. Schwartz, Tracie C. Walker, Keiko M. Tarquinio, Matt S. Zinter, Mary A. Staat, Shira J. Gertz, Natalie Z. Cvijanovich, Jennifer E. Schuster, Laura L. Loftis, Bria M. Coates, Elizabeth H. Mack, Katherine Irby, Julie C. Fitzgerald, Courtney M. Rowan, Michele Kong, Heidi R. Flori, Aline B. Maddux, Steven L. Shein, Hillary Crandall, Janet R. Hume, Charlotte V. Hobbs, Adriana H. Tremoulet, Chisato Shimizu, Jane C. Burns, Sabrina R. Chen, Hye Kyung Moon, Christoph Lange, Adrienne G. Randolph, Surender Khurana
Format: Article
Language:English
Published: Nature Portfolio 2022-05-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-022-30649-1
_version_ 1828348096667451392
author Juanjie Tang
Tanya Novak
Julian Hecker
Gabrielle Grubbs
Fatema Tuz Zahra
Lorenza Bellusci
Sara Pourhashemi
Janet Chou
Kristin Moffitt
Natasha B. Halasa
Stephanie P. Schwartz
Tracie C. Walker
Keiko M. Tarquinio
Matt S. Zinter
Mary A. Staat
Shira J. Gertz
Natalie Z. Cvijanovich
Jennifer E. Schuster
Laura L. Loftis
Bria M. Coates
Elizabeth H. Mack
Katherine Irby
Julie C. Fitzgerald
Courtney M. Rowan
Michele Kong
Heidi R. Flori
Aline B. Maddux
Steven L. Shein
Hillary Crandall
Janet R. Hume
Charlotte V. Hobbs
Adriana H. Tremoulet
Chisato Shimizu
Jane C. Burns
Sabrina R. Chen
Hye Kyung Moon
Christoph Lange
Adrienne G. Randolph
Surender Khurana
author_facet Juanjie Tang
Tanya Novak
Julian Hecker
Gabrielle Grubbs
Fatema Tuz Zahra
Lorenza Bellusci
Sara Pourhashemi
Janet Chou
Kristin Moffitt
Natasha B. Halasa
Stephanie P. Schwartz
Tracie C. Walker
Keiko M. Tarquinio
Matt S. Zinter
Mary A. Staat
Shira J. Gertz
Natalie Z. Cvijanovich
Jennifer E. Schuster
Laura L. Loftis
Bria M. Coates
Elizabeth H. Mack
Katherine Irby
Julie C. Fitzgerald
Courtney M. Rowan
Michele Kong
Heidi R. Flori
Aline B. Maddux
Steven L. Shein
Hillary Crandall
Janet R. Hume
Charlotte V. Hobbs
Adriana H. Tremoulet
Chisato Shimizu
Jane C. Burns
Sabrina R. Chen
Hye Kyung Moon
Christoph Lange
Adrienne G. Randolph
Surender Khurana
author_sort Juanjie Tang
collection DOAJ
description The antibody response to the SARS-CoV-2 Omicron variant is not well studied in children. Here, the authors provide an age-stratified analysis of SARS-CoV-2 neutralizing capacity of sera from children with acute or convalescent COVID-19 as well as children with multisystem inflammatory syndrome.
first_indexed 2024-04-14T00:49:21Z
format Article
id doaj.art-e95d32cb646c4ee9abe90f1a0721b0aa
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-04-14T00:49:21Z
publishDate 2022-05-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-e95d32cb646c4ee9abe90f1a0721b0aa2022-12-22T02:21:51ZengNature PortfolioNature Communications2041-17232022-05-0113111010.1038/s41467-022-30649-1Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-CJuanjie Tang0Tanya Novak1Julian Hecker2Gabrielle Grubbs3Fatema Tuz Zahra4Lorenza Bellusci5Sara Pourhashemi6Janet Chou7Kristin Moffitt8Natasha B. Halasa9Stephanie P. Schwartz10Tracie C. Walker11Keiko M. Tarquinio12Matt S. Zinter13Mary A. Staat14Shira J. Gertz15Natalie Z. Cvijanovich16Jennifer E. Schuster17Laura L. Loftis18Bria M. Coates19Elizabeth H. Mack20Katherine Irby21Julie C. Fitzgerald22Courtney M. Rowan23Michele Kong24Heidi R. Flori25Aline B. Maddux26Steven L. Shein27Hillary Crandall28Janet R. Hume29Charlotte V. Hobbs30Adriana H. Tremoulet31Chisato Shimizu32Jane C. Burns33Sabrina R. Chen34Hye Kyung Moon35Christoph Lange36Adrienne G. Randolph37Surender Khurana38Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDADepartment of Anesthesiology, Critical Care and Pain Medicine, Boston Children’s HospitalChanning Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical SchoolDivision of Viral Products, Center for Biologics Evaluation and Research (CBER), FDADivision of Viral Products, Center for Biologics Evaluation and Research (CBER), FDADivision of Viral Products, Center for Biologics Evaluation and Research (CBER), FDADivision of Viral Products, Center for Biologics Evaluation and Research (CBER), FDADepartment of Pediatrics, Boston Children’s Hospital and Harvard Medical SchoolDepartment of Pediatrics, Boston Children’s Hospital and Harvard Medical SchoolDivision of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical CenterDepartment of Pediatrics, University of North Carolina at Chapel Hill Children’s HospitalDepartment of Pediatrics, University of North Carolina at Chapel Hill Children’s HospitalDivision of Critical Care Medicine, Department of Pediatrics, Emory University School of Medicine, Children’s Healthcare of AtlantaDepartment of Pediatrics, Divisions of Critical Care and Bone Marrow Transplantation, University of California, San FranciscoDepartment of Pediatrics, University of Cincinnati, Division of Infectious Diseases, Cincinnati Children’s Hospital Medical CenterDivision of Pediatric Critical Care, Department of Pediatrics, Cooperman Barnabas Medical CenterDivision of Critical Care Medicine, UCSF Benioff Children’s Hospital OaklandDivision of Pediatric Infectious Diseases, Department of Pediatrics, Children’s Mercy Kansas CityDivision of Critical Care Medicine, Department of Pediatrics, Baylor College of MedicineDivision of Critical Care Medicine, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children’s Hospital of ChicagoDivision of Pediatric Critical Care Medicine, Medical University of South CarolinaSection of Pediatric Critical Care, Department of Pediatrics, Arkansas Children’s HospitalDivision of Critical Care, Department of Anesthesiology and Critical Care, The University of Pennsylvania Perelman School of MedicineDivision of Pediatric Critical Care Medicine, Department of Pediatrics, Indiana University School of Medicine, Riley Hospital for ChildrenDivision of Pediatric Critical Care Medicine, Department of Pediatrics, University of Alabama at BirminghamDivision of Pediatric Critical Care Medicine, Department of Pediatrics, Mott Children’s Hospital and University of MichiganDepartment of Pediatrics, Section of Critical Care Medicine, University of Colorado School of Medicine and Children’s Hospital ColoradoDivision of Pediatric Critical Care Medicine, Rainbow Babies and Children’s HospitalDivision of Pediatric Critical Care, Department of Pediatrics, University of UtahDivision of Pediatric Critical Care, University of Minnesota Masonic Children’s HospitalDepartment of Pediatrics, Department of Microbiology, Division of Infectious Diseases, University of Mississippi Medical CenterKawasaki Disease Research Center, Rady Children’s Hospital and Department of Pediatrics, UCSD School of MedicineKawasaki Disease Research Center, Rady Children’s Hospital and Department of Pediatrics, UCSD School of MedicineKawasaki Disease Research Center, Rady Children’s Hospital and Department of Pediatrics, UCSD School of MedicineDepartment of Anesthesiology, Critical Care and Pain Medicine, Boston Children’s HospitalDepartment of Anesthesiology, Critical Care and Pain Medicine, Boston Children’s HospitalDepartment of Biostatistics, Harvard T.H. Chan School of Public HealthDepartment of Anesthesiology, Critical Care and Pain Medicine, Boston Children’s HospitalDivision of Viral Products, Center for Biologics Evaluation and Research (CBER), FDAThe antibody response to the SARS-CoV-2 Omicron variant is not well studied in children. Here, the authors provide an age-stratified analysis of SARS-CoV-2 neutralizing capacity of sera from children with acute or convalescent COVID-19 as well as children with multisystem inflammatory syndrome.https://doi.org/10.1038/s41467-022-30649-1
spellingShingle Juanjie Tang
Tanya Novak
Julian Hecker
Gabrielle Grubbs
Fatema Tuz Zahra
Lorenza Bellusci
Sara Pourhashemi
Janet Chou
Kristin Moffitt
Natasha B. Halasa
Stephanie P. Schwartz
Tracie C. Walker
Keiko M. Tarquinio
Matt S. Zinter
Mary A. Staat
Shira J. Gertz
Natalie Z. Cvijanovich
Jennifer E. Schuster
Laura L. Loftis
Bria M. Coates
Elizabeth H. Mack
Katherine Irby
Julie C. Fitzgerald
Courtney M. Rowan
Michele Kong
Heidi R. Flori
Aline B. Maddux
Steven L. Shein
Hillary Crandall
Janet R. Hume
Charlotte V. Hobbs
Adriana H. Tremoulet
Chisato Shimizu
Jane C. Burns
Sabrina R. Chen
Hye Kyung Moon
Christoph Lange
Adrienne G. Randolph
Surender Khurana
Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C
Nature Communications
title Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C
title_full Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C
title_fullStr Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C
title_full_unstemmed Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C
title_short Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C
title_sort cross reactive immunity against the sars cov 2 omicron variant is low in pediatric patients with prior covid 19 or mis c
url https://doi.org/10.1038/s41467-022-30649-1
work_keys_str_mv AT juanjietang crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT tanyanovak crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT julianhecker crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT gabriellegrubbs crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT fatematuzzahra crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT lorenzabellusci crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT sarapourhashemi crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT janetchou crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT kristinmoffitt crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT natashabhalasa crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT stephaniepschwartz crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT traciecwalker crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT keikomtarquinio crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT mattszinter crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT maryastaat crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT shirajgertz crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT nataliezcvijanovich crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT jennifereschuster crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT lauralloftis crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT briamcoates crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT elizabethhmack crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT katherineirby crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT juliecfitzgerald crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT courtneymrowan crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT michelekong crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT heidirflori crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT alinebmaddux crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT stevenlshein crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT hillarycrandall crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT janetrhume crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT charlottevhobbs crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT adrianahtremoulet crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT chisatoshimizu crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT janecburns crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT sabrinarchen crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT hyekyungmoon crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT christophlange crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT adriennegrandolph crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc
AT surenderkhurana crossreactiveimmunityagainstthesarscov2omicronvariantislowinpediatricpatientswithpriorcovid19ormisc